Literature DB >> 7765926

Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells.

A Garnier1, J Côté, I Nadeau, A Kamen, B Massie.   

Abstract

Human 293S cells, a cell line adapted to suspension culture, were grown to 5 x 10(6) cells/mL in batch with calcium-free DMEM. These cells, infected with new constructions of adenovirus vectors, yielded as much as 10 to 20% recombinant protein with respect to the total cellular protein content. Until recently, high specific productivity of recombinant protein was limited to low cell density infected cultures of no more than 5 x 10(5) cells/mL. In this paper, we show with a model protein, Protein Tyrosine Phosphatase 1C, how product yield can be maintained at high cell densities of 2 x 10(6) cells/mL by a medium replacement strategy. This allows the production of as much as 90 mg/L of active recombinant protein per culture volume. Analysis of key limiting/inhibiting medium components showed that glucose addition along with pH control can yield the same productivity as a medium replacement strategy at high cell density in calcium-free DMEM. Finally, the above results were reproduced in 3L bioreactor suspension culture thereby establishing the scalability of this expression system. The process we developed is used routinely with the same success for the production of various recombinant proteins and viruses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7765926     DOI: 10.1007/BF00762389

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  10 in total

1.  Propagation of recombinant vaccinia virus in HeLa cells: adsorption kinetics and replication in batch cultures.

Authors:  R A Chillakuru; D D Ryu; T Yilma
Journal:  Biotechnol Prog       Date:  1991 Mar-Apr

Review 2.  Expression of heterologous sequences in adenoviral vectors.

Authors:  K L Berkner
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

3.  A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases.

Authors:  S H Shen; L Bastien; B I Posner; P Chrétien
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

4.  Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently.

Authors:  B Massie; J Dionne; N Lamarche; J Fleurent; Y Langelier
Journal:  Biotechnology (N Y)       Date:  1995-06

5.  Adenovirus-mediated gene transfer.

Authors:  R D Gerard; R S Meidell
Journal:  Trends Cardiovasc Med       Date:  1993 Sep-Oct       Impact factor: 6.677

Review 6.  Development of adenovirus vectors for the expression of heterologous genes.

Authors:  K L Berkner
Journal:  Biotechniques       Date:  1988 Jul-Aug       Impact factor: 1.993

7.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

8.  Growth of 293 cells in suspension culture.

Authors:  F L Graham
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

9.  Culture of insect cells in helical ribbon impeller bioreactor.

Authors:  A A Kamen; R L Tom; A W Caron; C Chavarie; B Massie; J Archambault
Journal:  Biotechnol Bioeng       Date:  1991-09       Impact factor: 4.530

10.  Purification and characterization of a protein tyrosine phosphatase containing SH2 domains.

Authors:  Z Zhao; P Bouchard; C D Diltz; S H Shen; E H Fischer
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

  10 in total
  24 in total

1.  New adenovirus vectors for protein production and gene transfer.

Authors:  B Massie; D D Mosser; M Koutroumanis; I Vitté-Mony; L Lamoureux; F Couture; L Paquet; C Guilbault; J Dionne; D Chahla; P Jolicoeur; Y Langelier
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

2.  Cell culture processes for the production of viral vectors for gene therapy purposes.

Authors:  James N Warnock; Otto-Wilhelm Merten; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2006-06-30       Impact factor: 2.058

3.  A high-yielding serum-free, suspension cell culture process to manufacture recombinant adenoviral vectors for gene therapy.

Authors:  G Schoofs; T J Monica; J Ayala; J Horwitz; T Montgomery; G Roth; F J Castillo
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

4.  Magic angle spinning NMR of the protonated retinylidene Schiff base nitrogen in rhodopsin: expression of 15N-lysine- and 13C-glycine-labeled opsin in a stable cell line.

Authors:  M Eilers; P J Reeves; W Ying; H G Khorana; S O Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

5.  Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette.

Authors:  B Massie; F Couture; L Lamoureux; D D Mosser; C Guilbault; P Jolicoeur; F Bélanger; Y Langelier
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

Review 6.  Adenovirus-mediated gene transfer into striated muscles.

Authors:  G Acsadi; B Massie; A Jani
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

Review 7.  Recent advances in mammalian protein production.

Authors:  Ashok D Bandaranayake; Steven C Almo
Journal:  FEBS Lett       Date:  2013-12-06       Impact factor: 4.124

8.  Transforming growth factor beta (TGFbeta) mediates Schwann cell death in vitro and in vivo: examination of c-Jun activation, interactions with survival signals, and the relationship of TGFbeta-mediated death to Schwann cell differentiation.

Authors:  D B Parkinson; Z Dong; H Bunting; J Whitfield; C Meier; H Marie; R Mirsky; K R Jessen
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

9.  Expression and Characterization of Human Vascular Endothelial Growth Factor Produced in SiHa Cells Transduced with Adenoviral Vector.

Authors:  N C Parra; R Mansilla; G Aedo; N S Vispo; E E González-Horta; I González-Chavarría; C Castillo; F Camacho; O Sánchez
Journal:  Protein J       Date:  2019-12       Impact factor: 2.371

10.  The expression of exogenous genes in macrophages: obstacles and opportunities.

Authors:  Xia Zhang; Justin P Edwards; David M Mosser
Journal:  Methods Mol Biol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.